Skip to content
ApprovedFDA approved

Clomid (Clomiphene Citrate)

Prescription fertility medicine for women; men use it off-label to raise testosterone, and it can cause mood problems.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Clomid (Clomiphene Citrate) vial

DETAILED OVERVIEW

What is Clomid (Clomiphene Citrate)?

Clomid (clomiphene citrate) is a prescription medicine approved in the United States in 1967 for female infertility caused by problems with ovulation; it is also registered in Hungary and Poland. In men it is used off-label for low testosterone and, after stopping anabolic steroids, to restart the body's own hormone production.

Its active ingredient is a mix of two components with opposite effects. One blocks the estrogen signal in the pituitary gland, so the gland releases more of the hormones that stimulate the testicles, and testosterone and sperm production start up. The other acts as a weak estrogen, builds up slowly and is behind the mood side effects: about 40–50% of users get mild to moderate low mood or emotional swings. Vision problems can also occur; they usually go away after stopping but are rarely permanent. It must not be used in pregnancy, because it can harm the baby. In competitive sport it is banned for men, both in and out of competition.

Mechanism

Non-steroidal SERM, racemic mixture (62% zuclo + 38% enclo)

Half-life

Zuclomiphene ~5-7 weeks accumulating / enclomiphene ~5 days

Onset

LH rise 5-10 days, Test recovery 3-4 weeks

Legal status

FDA + EMA Rx (female indication), off-label male hypogonadism, WADA S4 (banned)

Data console

Lab data

Androgenic:AnabolicN/A (not an AAS, SERM)
AR bindingER-α competitive affinity moderate-to-high…
Active half-lifeEnclomiphene ~5 days (PCT-active half)
Detection windowWADA-accredited GC-MS/LC-MS/MS urine detection 2-4 months after last Clomid dose (clomiphene + N-dealkylated metabolites). Longer than Nolvadex detection due to zuclomiphene accumulation.
AromatizationDoes not aromatize – competitive ER blockade, NOT aromatase inhibition. Clinically E2 rises slightly on Clomid (pituitary LH-disinhibition → testicular E2 synthesis, zuclomiphene intrinsic ER agonism adds further agonism). Higher E2 rebound than on Nolvadex.
HepatotoxicityLow – non-steroidal, NOT 17α-alkylated. Hepatic stress minimal. Extremely rare cholestasis cases documented in fertility trials (FDA Clomid SmPC adverse reactions); not clinically reported at AAS-PCT 4-6 week dosing.

Safety

Side effects, stop signs, contraindications

Side effects · 7

  • Mood disturbance: emotional lability, depressed mood, irritability, tearfulness (driven by the zuclomiphene isomer's central nervous-system estrogen-receptor agonism, mild-to-moderate in roughly 40-50% of users).
  • Visual disturbances: scintillating scotoma, blurred vision, light sensitivity, afterimages. Usually dose-dependent (chronic >100 mg/day) and reversible on discontinuation, but persistent visual impairment is reported in rare cases.
  • Estradiol elevation (E2 rebound): increased testicular estradiol production via raised LH, plus the weak intrinsic estrogenic activity of zuclomiphene. Can cause water retention, gynecomastia flare-ups and headache; more pronounced than with Nolvadex.
  • Headache, nausea, hot flushes and dizziness: common estrogen-receptor-modulator side effects, generally mild and dose-dependent.
  • Mild rise in blood glucose (fasting glucose) via an indirect metabolic effect of zuclomiphene; warrants extra monitoring in diabetes or prediabetes.
  • Ovarian hyperstimulation syndrome (OHSS) and multiple pregnancy with female ovulation-induction use: abdominal distension, enlarged ovaries and, in severe cases, fluid accumulation (not relevant to male PCT use).
  • Rare cholestasis and liver-enzyme elevation: documented as a rare event in fertility trials; it is not 17-alpha-alkylated, so overall hepatotoxicity is low.

Contraindications · 7

  • Pregnancy (Category X): clomiphene can cause fetal harm and is strictly contraindicated during pregnancy; pregnancy must be excluded before treatment in women.
  • Psychiatric history (major depression, bipolar disorder, severe anxiety): the mood lability and depressive effect can trigger or worsen the condition, so it is contraindicated or requires close psychiatric supervision.
  • Active liver disease or hepatic dysfunction: a relative contraindication due to hepatic metabolism and the rare cholestasis risk; avoid in liver disease.
  • Pre-existing visual disturbance: clomiphene can cause visual-field and vision complaints, so treatment is contraindicated or should be started only under ophthalmologic monitoring if a visual disturbance is present.
  • Undiagnosed abnormal uterine bleeding or estrogen-dependent tumor (e.g. history of ovarian tumor): must be excluded before treatment, as hormonal stimulation may worsen it.
  • Untreated thyroid or adrenal dysfunction, or pituitary tumor: these must be diagnosed and treated before starting, as they distort the HPTA-axis response.
  • Competitive sport: listed on the WADA prohibited list (S4.3 estrogen-receptor modulator), banned both in- and out-of-competition for male athletes.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Clomid (Clomiphene Citrate)?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.